Cargando…
94 High Immunogenicity of the Allergen PHL P 5 Expressed in Transgenic Mice as a Membrane-anchored Protein
BACKGROUND: Induction of long-term tolerance towards Phl p 5 was previously achieved by transplantation of hematopoetic stem cells (HSCs) genetically modified to express membrane-bound Phl p 5 allergen. To facilitate the further development of tolerogenic cell therapies for allergy, a transgenic mou...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization Journal
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512942/ http://dx.doi.org/10.1097/01.WOX.0000411839.09657.43 |
_version_ | 1782251838421073920 |
---|---|
author | Farkas, Andreas Baranyi, Ulrike Valenta, Rudolf Wekerle, Thomas |
author_facet | Farkas, Andreas Baranyi, Ulrike Valenta, Rudolf Wekerle, Thomas |
author_sort | Farkas, Andreas |
collection | PubMed |
description | BACKGROUND: Induction of long-term tolerance towards Phl p 5 was previously achieved by transplantation of hematopoetic stem cells (HSCs) genetically modified to express membrane-bound Phl p 5 allergen. To facilitate the further development of tolerogenic cell therapies for allergy, a transgenic mouse expressing Phl p 5 ubiquitously as membrane-anchored protein, was generated. Here we investigated the immunogenicity of the membrane-anchored version of Phl p 5. METHODS: The Phl p 5-transgenic mouse (Balb/c background) was generated by pronuclear injection integrating Phl p 5 fused to a leader peptide and a transmembrane domain under control of a CMV-promotor with a GFP-reporter. Splenocytes (2.5 × 10(6) per mouse), cell extracts containing mainly membrane proteins and recombinant (r) Phl p 5 [5 μg+/− Al(OH)(3) per mouse] were injected subcutaneously into naïve Balb/c mice (n = 8 per group). The amount of Phl p 5 of splenocytes and cell extracts was semi-quantitatively determined via western blotting. Furthermore skin of Phl p 5-transgenic mice was grafted onto naïve Balb/c (n = 13 in 2 independent experiments), a rejection model in allo-transplantation since skin is highly immunogenic and therefore readily rejected. Phl p 5-specific antibody response was determined in sera by ELISAs. For T-cell responses splenocyte-proliferation was assessed in vitro after stimulation with rPhl p 5. RESULTS: Surprisingly, a prompt rejection (within 8-10 days) was elicited, accompanied by a strong Phl p 5 specific antibody response including Phl p 5-specific IgE in wildtype Balb/c after skin rejection of Phl p 5-transgenic mice. Additionally to the skin grafted group, mice receiving splenocytes or rPhl p 5 plus adjuvant showed a comparable response in matters of Phl p 5-specific IgE- and IgG1-levels through the whole follow-up (week 1, 2, 3, 5, 7, 9, 11) suggesting an unusually strong immune response to cell or tissue-bound Phl p 5. Furthermore Phl p 5-specific IgG2a/2b/3, IgA and IgM were induced. Besides in vitro splenocyte-proliferation assays showed Phl p 5 specific T-cell responses in all groups of mice that showed strong humoral responses. CONCLUSIONS: The high immunogenicity of tissue-bound Phl p 5 may represent a new mode of rendering antigens highly immunogenic. |
format | Online Article Text |
id | pubmed-3512942 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | World Allergy Organization Journal |
record_format | MEDLINE/PubMed |
spelling | pubmed-35129422012-12-21 94 High Immunogenicity of the Allergen PHL P 5 Expressed in Transgenic Mice as a Membrane-anchored Protein Farkas, Andreas Baranyi, Ulrike Valenta, Rudolf Wekerle, Thomas World Allergy Organ J Abstracts of the XXII World Allergy Congress BACKGROUND: Induction of long-term tolerance towards Phl p 5 was previously achieved by transplantation of hematopoetic stem cells (HSCs) genetically modified to express membrane-bound Phl p 5 allergen. To facilitate the further development of tolerogenic cell therapies for allergy, a transgenic mouse expressing Phl p 5 ubiquitously as membrane-anchored protein, was generated. Here we investigated the immunogenicity of the membrane-anchored version of Phl p 5. METHODS: The Phl p 5-transgenic mouse (Balb/c background) was generated by pronuclear injection integrating Phl p 5 fused to a leader peptide and a transmembrane domain under control of a CMV-promotor with a GFP-reporter. Splenocytes (2.5 × 10(6) per mouse), cell extracts containing mainly membrane proteins and recombinant (r) Phl p 5 [5 μg+/− Al(OH)(3) per mouse] were injected subcutaneously into naïve Balb/c mice (n = 8 per group). The amount of Phl p 5 of splenocytes and cell extracts was semi-quantitatively determined via western blotting. Furthermore skin of Phl p 5-transgenic mice was grafted onto naïve Balb/c (n = 13 in 2 independent experiments), a rejection model in allo-transplantation since skin is highly immunogenic and therefore readily rejected. Phl p 5-specific antibody response was determined in sera by ELISAs. For T-cell responses splenocyte-proliferation was assessed in vitro after stimulation with rPhl p 5. RESULTS: Surprisingly, a prompt rejection (within 8-10 days) was elicited, accompanied by a strong Phl p 5 specific antibody response including Phl p 5-specific IgE in wildtype Balb/c after skin rejection of Phl p 5-transgenic mice. Additionally to the skin grafted group, mice receiving splenocytes or rPhl p 5 plus adjuvant showed a comparable response in matters of Phl p 5-specific IgE- and IgG1-levels through the whole follow-up (week 1, 2, 3, 5, 7, 9, 11) suggesting an unusually strong immune response to cell or tissue-bound Phl p 5. Furthermore Phl p 5-specific IgG2a/2b/3, IgA and IgM were induced. Besides in vitro splenocyte-proliferation assays showed Phl p 5 specific T-cell responses in all groups of mice that showed strong humoral responses. CONCLUSIONS: The high immunogenicity of tissue-bound Phl p 5 may represent a new mode of rendering antigens highly immunogenic. World Allergy Organization Journal 2012-02-17 /pmc/articles/PMC3512942/ http://dx.doi.org/10.1097/01.WOX.0000411839.09657.43 Text en Copyright © 2012 by World Allergy Organization |
spellingShingle | Abstracts of the XXII World Allergy Congress Farkas, Andreas Baranyi, Ulrike Valenta, Rudolf Wekerle, Thomas 94 High Immunogenicity of the Allergen PHL P 5 Expressed in Transgenic Mice as a Membrane-anchored Protein |
title | 94 High Immunogenicity of the Allergen PHL P 5 Expressed in Transgenic Mice as a Membrane-anchored Protein |
title_full | 94 High Immunogenicity of the Allergen PHL P 5 Expressed in Transgenic Mice as a Membrane-anchored Protein |
title_fullStr | 94 High Immunogenicity of the Allergen PHL P 5 Expressed in Transgenic Mice as a Membrane-anchored Protein |
title_full_unstemmed | 94 High Immunogenicity of the Allergen PHL P 5 Expressed in Transgenic Mice as a Membrane-anchored Protein |
title_short | 94 High Immunogenicity of the Allergen PHL P 5 Expressed in Transgenic Mice as a Membrane-anchored Protein |
title_sort | 94 high immunogenicity of the allergen phl p 5 expressed in transgenic mice as a membrane-anchored protein |
topic | Abstracts of the XXII World Allergy Congress |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512942/ http://dx.doi.org/10.1097/01.WOX.0000411839.09657.43 |
work_keys_str_mv | AT farkasandreas 94highimmunogenicityoftheallergenphlp5expressedintransgenicmiceasamembraneanchoredprotein AT baranyiulrike 94highimmunogenicityoftheallergenphlp5expressedintransgenicmiceasamembraneanchoredprotein AT valentarudolf 94highimmunogenicityoftheallergenphlp5expressedintransgenicmiceasamembraneanchoredprotein AT wekerlethomas 94highimmunogenicityoftheallergenphlp5expressedintransgenicmiceasamembraneanchoredprotein |